Twist Bioscience Corp vs Vanguard Information Technology Index Fund ETF — how do they compare? Twist Bioscience Corp trades at $88.31 (market cap $5.45B), while Vanguard Information Technology Index Fund ETF trades at $115.93. Which is the better fit depends on your goals.
| TWST | VGT | |
|---|---|---|
Market Cap | $5.45B | — |
Sector | Health | — |
52-Week High | $102.88 | $125.77 |
52-Week Low | $24.16 | $83.59 |
Enterprise Value | $5.37B | — |
Trailing returns across standard periods
Latest headlines on both assets
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index/Information Technology 25/50, an index made up of stocks of large, mid-size, and small US companies within the information technology sector, as classified under the GICS. The advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VGT →